Sen. Bernie Sanders (I-Vermont) has condemned the Biden administration’s decision this week to reject a request to lower the price of an extremely expensive prostate cancer drug that can help extend the lives of patients for months or years. Failing what advocates considered a litmus test of the administration’s willingness to act on prescription drug prices on Tuesday, the National Institutes of…